Tag: Biotechnologies

Biotechnology is the use of living systems and organisms to develop or make products, or “any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use”. Depending on the tools and applications, it often overlaps with the (related) fields of bioengineering, biomedical engineering, biomanufacturing, molecular engineering, etc.

Stealth BioTherapeutics obtains financing for development of clinical program

Stealth BioTherapeutics, a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of mitochondrial dysfunction, announced the closing of $100 million of financing.

Plantform Corporation received a patent from the European Patent Office

PlantForm Corporation has been granted a patent by the European Patent Office – Methods of Improving the Therapeutic Efficacy and Utility of Antibody Fragments – under patent No. 2355849.

Russian nationwide network of biobanks will help to develop new drugs

According to Vitaly Prutsky, the head of National BioService (NBS), this project provides for developing the All-Russian network of biobanks.

LR Group will set up shared biotech hub in Jerusalem

LR Group will build three workspaces for biotechnology and medical startups near hospitals in Israel - Hadassah Medical Center Ein Kerem in Jerusalem, Rabin Medical Center in Petah Tikva and Rambam Health Care Campus in Haifa.

Sechenov University develops “the medicine of the future”

The work to establish Biomedicine Science and Technology Park, a high-tech and knowledge-intensive interdisciplinary cluster, is in full swing. Several new labs, including international ones, are scheduled for opening this year.

Stelis Biopharma and Oncobiologics start a new CDMO

Marketed under the name, Bio2Source, Oncobiologics and Stelis Biopharma will offer development stage biotech companies access to a suite of CDMO services.

Lonza announced a distribution agreement with Innosieve Diagnostics

Lonza Pharma & Biotech and Innosieve Diagnostics announced an exclusive distribution agreement for rapid bioburden testing technology.

Lyonbiopole will bring together leading French biotech companies

Lyonbiopole, the French bio-cluster based in the Auvergne-Rhône-Alpes region, will unite 35 innovative organizations at the 2018 edition of the BIO International Convention.

BioTime received $1.9 million grant from the Israel Innovation Authority

BioTime, a clinical-stage biotechnology company focused on degenerative diseases, has been awarded a new grant for 2018 of up to $1.9 million from the Israel Innovation Authority (IIA).

Russian Ministry included the Kirov region biotech cluster in its register

The industrial cluster became the first in the region to have been included in the list of industrial clusters and specialized organizations of industrial clusters of the Ministry of Industry and Trade of Russia.

Kaneka Corporation invests in Spanish biotech company

Kaneka Corporation (Tokyo, Japan) acquired a 34.8% share of AB-Biotics (Barcelona, Spain), a Spanish biotech company focusing on research, development, and distribution of its own products using lactic acid bacteria.

Wyss Institute intends to recode the human genome jointly with Celectis

The Wyss Institute for Biologically Inspired Engineering at Harvard University and Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies, announced that they will collaborate.

Synpromics entered a biopharmaceutical partnership with Lonza

gene editing
Synpromics Ltd, the leader in gene control, announced a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals.

Gilead Sciences and Verily Life Sciences start a scientific collaboration

Gilead Sciences and Verily Life Sciences announced a scientific collaboration using Verily’s platform to identify and better understand the immunological basis of three common and serious inflammatory diseases.

United Therapeutics buys specialty pharmaceutical company SteadyMed

test tube
United Therapeutics Corporation and SteadyMed Ltd announced the signing of a definitive merger agreement under which United Therapeutics will acquire SteadyMed. The transaction is valued at $216 million.

New biotechnology park is launched in Armenia

The FMD K&L Europe opened the largest biotechnology park in Yerevan. The list of participants of the ceremony included foreign ambassadors, world leading biotechnology, pharmaceutical, financial, IT and other leading figures.